These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 2672244

  • 1. Pharmacokinetics of fluorinated 4-quinolones in the aged.
    Norrby SR, Ljungberg B.
    Rev Infect Dis; 1989; 11 Suppl 5():S1102-6. PubMed ID: 2672244
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R, Griggs D, Andrews JM.
    Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [Abstract] [Full Text] [Related]

  • 3. Quinolone disposition in the elderly. Practical implications.
    Nilsson-Ehle I, Ljungberg B.
    Drugs Aging; 1991; 1(4):279-88. PubMed ID: 1794020
    [Abstract] [Full Text] [Related]

  • 4. Influence of renal function on the pharmacokinetics of lomefloxacin compared with other fluoroquinolones.
    Blum RA.
    Am J Med; 1992 Apr 06; 92(4A):18S-21S. PubMed ID: 1316065
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of quinolones in renal insufficiency.
    Fillastre JP, Leroy A, Moulin B, Dhib M, Borsa-Lebas F, Humbert G.
    J Antimicrob Chemother; 1990 Oct 06; 26 Suppl B():51-60. PubMed ID: 2124213
    [Abstract] [Full Text] [Related]

  • 6. Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.
    Wijnands WJ, Vree TB, Baars AM, van Herwaarden CL.
    Drugs; 1987 Oct 06; 34 Suppl 1():159-69. PubMed ID: 3481317
    [Abstract] [Full Text] [Related]

  • 7. The pharmacokinetics and tissue penetration of the fluoroquinolones.
    Bergeron MG.
    Clin Invest Med; 1989 Feb 06; 12(1):20-7. PubMed ID: 2920479
    [Abstract] [Full Text] [Related]

  • 8. The comparative pharmacokinetics of five quinolones.
    Wise R, Lister D, McNulty CA, Griggs D, Andrews JM.
    J Antimicrob Chemother; 1986 Nov 06; 18 Suppl D():71-81. PubMed ID: 3468102
    [Abstract] [Full Text] [Related]

  • 9. Comparative pharmacokinetics of new quinolones.
    Lode H, Höffken G, Prinzing C, Glatzel P, Wiley R, Olschewski P, Sievers B, Reimnitz D, Borner K, Koeppe P.
    Drugs; 1987 Nov 06; 34 Suppl 1():21-5. PubMed ID: 3481323
    [Abstract] [Full Text] [Related]

  • 10. Quinolone pharmacokinetics and metabolism.
    Lode H, Höffken G, Boeckk M, Deppermann N, Borner K, Koeppe P.
    J Antimicrob Chemother; 1990 Oct 06; 26 Suppl B():41-9. PubMed ID: 2124212
    [Abstract] [Full Text] [Related]

  • 11. Accumulation of new quinolones in the blood of elderly patients.
    Morita M, Hasuda A, Nakagawa H, Abe Y, Suzuki K.
    J Int Med Res; 1993 Oct 06; 21(6):334-41. PubMed ID: 8143888
    [Abstract] [Full Text] [Related]

  • 12. The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin.
    Wise R, Lister D, McNulty CA, Griggs D, Andrews JM.
    Infection; 1986 Oct 06; 14 Suppl 3():S196-202. PubMed ID: 3463542
    [Abstract] [Full Text] [Related]

  • 13. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
    Renaudin H, Quentin C, de Barbeyrac B, Bebear C.
    Pathol Biol (Paris); 1988 May 06; 36(5):496-9. PubMed ID: 3136430
    [Abstract] [Full Text] [Related]

  • 14. Clinical pharmacokinetics of the newer antibacterial 4-quinolones.
    Neuman M.
    Clin Pharmacokinet; 1988 Feb 06; 14(2):96-121. PubMed ID: 3282749
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of drug metabolism by quinolone antibiotics.
    Edwards DJ, Bowles SK, Svensson CK, Rybak MJ.
    Clin Pharmacokinet; 1988 Sep 06; 15(3):194-204. PubMed ID: 3052987
    [Abstract] [Full Text] [Related]

  • 16. Drug interactions with quinolones.
    Janknegt R.
    J Antimicrob Chemother; 1990 Nov 06; 26 Suppl D():7-29. PubMed ID: 2286594
    [Abstract] [Full Text] [Related]

  • 17. In vitro susceptibility of aerobic gram-negative blood culture isolates to oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacin.
    Van der Auwera P.
    Infection; 1986 Nov 06; 14(3):142-4. PubMed ID: 2942489
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of quinolones: newer aspects.
    Wolfson JS, Hooper DC.
    Eur J Clin Microbiol Infect Dis; 1991 Apr 06; 10(4):267-74. PubMed ID: 1864287
    [Abstract] [Full Text] [Related]

  • 19. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D, O'Hare MD, Robbins MJ, Wall RA, Williams AH, Cremer AW, Ridgway GL, Grüneberg RN.
    Drugs Exp Clin Res; 1985 Apr 06; 11(5):317-29. PubMed ID: 2941259
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of ciprofloxacin.
    Bergan T, Dalhoff A, Rohwedder R.
    Infection; 1988 Apr 06; 16 Suppl 1():S3-13. PubMed ID: 3286512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.